PROTEOSTASIS THERAPEUTICS
Dead / Cancelled — Cancelled — Section 8 (as of 21 Aug 2026)
What this means for you
This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 88363795
- Registration number
- 5986569
- Mark type
- Stylized text
- Filed
- 29 Mar 2019
- Registered
- 11 Feb 2020
- Attorney of record
- John L. DuPre'
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of disorders in the nature of digestive disorders, ophthalmic disorders, hepatic disorders, respiratory disorders, sweat disorder, pancreatic disorders, reproductive disorders, and endocrine disorders; medical diagnostic assays for testing of body fluids; medical diagnostic assays for testing human cells for responses to therapy
Owner
- Proteostasis Therapeutics, Inc., Boston, MA, US
- Proteostasis Therapeutics, Inc., Boston, MA, US
Prosecution history
- 21 Aug 2026 — CANCELLED SEC. 8 (6-YR)
- 11 Feb 2025 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 11 Feb 2020 — REGISTERED-SUPPLEMENTAL REGISTER
- 03 Jan 2020 — LAW OFFICE PUBLICATION REVIEW COMPLETED
- 26 Dec 2019 — ASSIGNED TO LIE
- 24 Dec 2019 — NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
- 21 Dec 2019 — APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
- 21 Dec 2019 — USE AMENDMENT ACCEPTED
- 21 Dec 2019 — AMENDMENT TO USE PROCESSING COMPLETE
- 21 Dec 2019 — USE AMENDMENT FILED
- 20 Dec 2019 — TEAS AMENDMENT OF USE RECEIVED
- 20 Dec 2019 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 20 Dec 2019 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 20 Dec 2019 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 20 Jun 2019 — NOTIFICATION OF NON-FINAL ACTION E-MAILED